Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
760 studies found for:    Open Studies | "Stem Cell Transplantation"
Show Display Options
Rank Status Study
21 Recruiting NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair
Condition: Spinal Cord Injury
Interventions: Biological: NeuroRegen scaffold/mesenchymal stem cells transplantation;   Biological: NeuroRegen scaffold/neural stem cells transplantation
22 Recruiting Autologous Stem Cell Transplantation for Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: autologous CD34-selected peripheral blood stem cells transplant
23 Recruiting Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis
Conditions: Scleroderma;   Cardiac Involvement;   Autologous Stem Cell Transplantation
Intervention: Drug: Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
24 Recruiting Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)
Condition: Systemic Lupus Erythematosus
Intervention: Procedure: Immunoablation and Autologous Hematopoietic Stem Cell Transplantation
25 Recruiting Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Procedure: Donor Bone Marrow stem cell transplantation
26 Recruiting Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
Condition: Recurrent Nasopharynx Carcinoma
Interventions: Drug: Etoposide phosphate;   Drug: Carboplatin;   Drug: Ifosfamide;   Procedure: Autologous Stem Cell Transplantation
27 Recruiting Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
Condition: Hodgkin Lymphoma
Interventions: Drug: Brentuximab Vedotin;   Procedure: Allogeneic Stem Cell Transplantation;   Drug: Reduced Intensity Conditioning
28 Recruiting Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)
Condition: Sickle Cell Disease
Interventions: Procedure: Allogeneic Non-Myeloablative Stem Cell Transplantation;   Drug: Alemtuzumab;   Drug: Sirolimus
29 Recruiting Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diseases;   Endocrine System Diseases;   Glucose Metabolism Disorders;   Immune System Diseases;   Metabolic Diseases
Intervention: Biological: Stem Cell Transplantation
30 Recruiting Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.
Condition: Non-obstructive Azoospermia
Intervention: Biological: Stem Cell Transplantation
31 Recruiting Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia
Condition: Waldenström Macroglobulinemia
Interventions: Other: autologous stem cell transplantation;   Other: conventional chemotherapy
32 Recruiting HPV Antibody Response After GARDASIL 9 Vaccination in Participants After Allogeneic Stem Cell Transplantation
Condition: HPV Infection
Intervention: Biological: GARDASIL 9
33 Recruiting Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases
Conditions: Graft Versus Host Disease;   Hematopoietic/Lymphoid Cancer
Interventions: Drug: fludarabine phosphate;   Drug: busulfan;   Drug: cyclophosphamide;   Procedure: allogeneic hematopoietic stem cell transplantation;   Drug: tacrolimus;   Drug: mycophenolate mofetil
34 Recruiting Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT
Conditions: Myeloid Leukemia;   Precursor Myeloid Neoplasms;   Lymphoid Neoplasms
Interventions: Drug: Busulfan-Cyclophosphamide as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide-Busulfan as Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation
35 Recruiting Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission
Conditions: Acute Myeloid Leukemia;   Acute Lymphoid Leukemia
Interventions: Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: CXCR4 Antagonist;   Procedure: Hematopoietic Stem Cell Transplantation
36 Recruiting Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients
Conditions: Triple-Negative Invasive Breast Carcinoma;   Residual Tumor
Interventions: Drug: Carmustine;   Drug: Cyclophosphamide;   Drug: Carboplatin;   Procedure: Autologous Hematopoietic Stem Cell Transplantation
37 Recruiting Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation
Condition: Bronchiolitis Obliterans Syndrome
Interventions: Procedure: Pulmonary function testing;   Drug: FAM Therapy
38 Recruiting Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies
Condition: Stem Cell Transplant Complications
Interventions: Drug: Zinc Sulfate Oral Product;   Drug: Levofloxacin 500Mg Oral Tablet;   Drug: Fluconazole 200mg tab;   Drug: Acyclovir 400 MG
39 Recruiting Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Conditions: Diffuse Large B-cell Lymphoma (DLBCL);   Relapsed Diffuse Large B-cell Lymphoma (DLBCL);   Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Interventions: Procedure: leukapheresis;   Drug: Plerixafor;   Drug: carmustine, etoposide, cytarabine, melphalan;   Procedure: Autologous Stem Cell Transplantation
40 Recruiting Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
Conditions: Myelodysplastic Syndromes (MDS);   Acute Myelogenous Leukemia (AML)
Intervention: Drug: low dose 5'-azacitidine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.